Surgical Treatments for Vulvar and Vaginal Dysplasia
- 1 April 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 109 (4), 942-947
- https://doi.org/10.1097/01.aog.0000258783.49564.5c
Abstract
To compare pain, adverse effects and recurrence of dysplasia in patients with vaginal intraepithelial neoplasia or vulvar intraepithelial neoplasia prospectively treated by carbon dioxide laser or ultrasonic surgical aspiration. Patients were randomly assigned to receive treatment by laser or ultrasonic surgical aspiration from 2000-2005. Preoperative biopsy was done to confirm presence of dysplasia. Patients completed a visual analog scale regarding pain and were evaluated at 2-4 weeks to assess scarring, wound healing, and adverse effects. Patients returned every 3 months for 1 year for pelvic examination and cytology to assess recurrence. Follow-up colposcopy and biopsy were used at the discretion of the treating physician. Student t test, chi2, analysis of variance and multiple logistic regression were used for analysis. One hundred ten patients were randomly assigned. Ninety-six (87.3%) patients completed 1 year follow-up. Mean age of patients was 48.5 years. Mean visual analog scale score was significantly lower in patients treated by ultrasonic surgical aspiration (20.7 compared with 35.1; P=.032). For patients with vulvar lesions, there was less scarring with ultrasonic surgical aspiration (P<.01). Recurrence overall was 25% and was similar for ultrasonic surgical aspiration compared with laser (relative risk 0.96, 95% confidence interval 0.64-1.50, number needed to treat 95.6). Recurrence was associated with younger age (P<.01). Patients treated with ultrasonic surgical aspiration for vulvar and vaginal dysplasia reported less postoperative pain. Vulvar scarring was more common in patients treated by the laser. There was no difference in recurrence of dysplasia during a 1-year follow-up period between the two surgical modalities. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00394758 I.Keywords
This publication has 22 references indexed in Scilit:
- Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomyGynecologic Oncology, 2006
- Preliminary results of 5% immiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3American Journal of Obstetrics and Gynecology, 2006
- Vulvar Intraepithelial NeoplasiaObstetrics & Gynecology, 2005
- Can local application of imiquimod cream be an alternative mode of therapy for patients with high-grade intraepithelial lesions of the vagina?International Journal of Gynecologic Cancer, 2005
- The Effects of 5% Imiquimod Cream on High-Grade Vulval Intraepithelial NeoplasiaGynecologic Oncology, 2002
- Vulvar Intraepithelial Neoplasia Treated with Cavitational Ultrasonic Surgical AspirationGynecologic Oncology, 2002
- Cavitational Ultrasonic Surgical Aspiration for the Treatment of Vaginal Intraepithelial NeoplasiaGynecologic Oncology, 2000
- A comparison of wound healing after epithelial resection by ultrasonic surgical aspiration and ablation by the carbon dioxide laserGynecologic Oncology, 1992
- Pathologic evaluation of gynecologic specimens obtained with the Cavitron Ultrasonic Surgical Aspirator (CUSA)Gynecologic Oncology, 1992
- Radiotherapy in the management of vaginal intraepithelial neoplasia after hysterectomyBJOG: An International Journal of Obstetrics and Gynaecology, 1988